Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for IOVA

Stock Name	Iovance Biotherapeutics Inc
Ticker	IOVA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US4622601007
LEI	2549002L8WT2ACU5Q878

Show aggregate IOVA holdings

News associated with IOVA

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Pass Below Two Hundred Day Moving Average – Here’s What Happened: Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.62 and traded as low as $2.19. Iovance Biotherapeutics shares last traded at $2.22, with a volume of 9,006,027 shares trading hands. Analyst Upgrades and Downgrades A number […] - 2025-09-18 04:49:17
After Hours Most Active for Aug 21, 2025 : NVDA, AMZN, LCID, AAPL, IOVA, AVGO: The NASDAQ 100 After Hours Indicator is down -18.44 to 23,124.14. The total After hours volume is currently 97,306,839 shares traded.The following are the most active stocks for the after hours session: NVIDIA Corporation (NVDA) is -0.07 at $174.91, with 4,892,038 shares traded. - 2025-08-21 17:24:54
HC Wainwright Reiterates Buy Rating for Iovance Biotherapeutics (NASDAQ:IOVA): Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They presently have a $20.00 price target on the biotechnology company’s stock. Other equities analysts have also recently issued research reports about the stock. Truist Financial cut […] - 2025-08-21 04:24:45
Top Stocks To Watch: IOVA Soars On Regulatory Approval, FDA Fast Tracks Aldeyra's Drug: (RTTNews) - PainReform Ltd.'s (PRFX) solar energy business unit, developing next-generation AI-driven solar analytics, DeepSolar, has been accepted into the NVIDIA Connect Program. This gives DeepSolar access to NVIDIA's AI frameworks, development tools, and engineering support t - 2025-08-19 10:36:15
Pre-Market Most Active for Aug 19, 2025 : OPEN, INTC, IOVA, TGNA, TSLL, JNJ, SQQQ, WMT, NVO, NVDA, XPEV, NIO: The NASDAQ 100 Pre-Market Indicator is down -14.36 to 23,699.4. The total Pre-Market volume is currently 178,882,121 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.38 at $4.16, with 20,195,663 shares trad - 2025-08-19 09:29:56
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Purchased by Chicago Partners Investment Group LLC: Chicago Partners Investment Group LLC grew its position in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 97.6% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,626 shares of the biotechnology company’s stock after purchasing an additional 20,067 shares […] - 2025-08-13 04:56:58
Iovance Biotherapeutics (NASDAQ:IOVA) Shares Down 5% After Analyst Downgrade: Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) shares dropped 5% during mid-day trading on Monday after Wells Fargo & Company lowered their price target on the stock from $18.00 to $14.00. Wells Fargo & Company currently has an overweight rating on the stock. Iovance Biotherapeutics traded as low as $2.02 and last traded at […] - 2025-08-12 02:18:51
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Acquired by Avantax Advisory Services Inc.: Avantax Advisory Services Inc. raised its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 39.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 18,560 shares of the biotechnology company’s stock after acquiring an additional 5,205 shares during the […] - 2025-08-11 06:04:48
XTX Topco Ltd Takes Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA): XTX Topco Ltd bought a new stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 181,832 shares of the biotechnology company’s stock, valued at approximately $606,000. A number of other large […] - 2025-08-06 05:20:52
TD Asset Management Inc Sells 171,200 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA): TD Asset Management Inc lowered its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 55.0% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 139,878 shares of the biotechnology company’s stock after selling 171,200 shares during the period. TD Asset Management Inc’s holdings in […] - 2025-08-05 05:32:52
This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?: Key PointsIovance launched its first product, called Amtagvi, last year. - 2025-07-29 04:29:00
Iovance Biotherapeutics Target of Unusually High Options Trading (NASDAQ:IOVA): Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) was the target of some unusual options trading on Wednesday. Traders bought 53,902 call options on the company. This is an increase of approximately 956% compared to the average volume of 5,106 call options. Institutional Trading of Iovance Biotherapeutics A number of hedge funds and other institutional […] - 2025-07-25 04:24:55
Noteworthy Wednesday Option Activity: AFRM, ADI, IOVA: Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Affirm Holdings Inc (Symbol: AFRM), where a total of 29,448 contracts have traded so far, representing approximately 2.9 million underlying shares. That amounts to about - 2025-07-23 16:27:11
Iovance Biotherapeutics (NASDAQ:IOVA) Stock Rating Lowered by The Goldman Sachs Group: Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) was downgraded by research analysts at The Goldman Sachs Group from a “neutral” rating to a “sell” rating in a research note issued on Tuesday, MarketBeat reports. A number of other research analysts have also recently weighed in on the stock. Chardan Capital cut their price objective on […] - 2025-07-17 05:14:57
Iovance Biotherapeutics (NASDAQ:IOVA) Downgraded to Sell Rating by The Goldman Sachs Group: Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) was downgraded by The Goldman Sachs Group from a “neutral” rating to a “sell” rating in a research report issued on Tuesday, MarketBeat reports. Several other research analysts have also issued reports on IOVA. JMP Securities reiterated a “market perform” rating on shares of Iovance Biotherapeutics in a […] - 2025-07-17 05:14:57
Iovance Biotherapeutics (NASDAQ:IOVA) Rating Lowered to “Sell” at The Goldman Sachs Group: Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) was downgraded by equities researchers at The Goldman Sachs Group from a “neutral” rating to a “sell” rating in a report issued on Tuesday, MarketBeat.com reports. Several other analysts also recently commented on IOVA. UBS Group downgraded Iovance Biotherapeutics from a “buy” rating to a “neutral” rating and […] - 2025-07-17 05:14:57
Cambridge Investment Research Advisors Inc. Buys 5,237 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA): Cambridge Investment Research Advisors Inc. lifted its stake in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 12.9% in the 1st quarter, Holdings Channel reports. The institutional investor owned 45,877 shares of the biotechnology company’s stock after acquiring an additional 5,237 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Iovance Biotherapeutics were […] - 2025-07-15 04:17:30
After Hours Most Active for Jun 6, 2025 : IOVA, NVDA, INTC, ACHR, AAL, CSX, AAPL, NKE, PCG, BAC, MRK, PFE: The NASDAQ 100 After Hours Indicator is up 14.86 to 21,776.65. The total After hours volume is currently 96,255,289 shares traded.The following are the most active stocks for the after hours session: Iovance Biotherapeutics, Inc. (IOVA) is +0.02 at $2.07, with 5,435,272 shares t - 2025-06-06 17:24:57
Ameriprise Financial Inc. Has $463,000 Stock Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA): Ameriprise Financial Inc. lessened its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 88.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 62,548 shares of the biotechnology company’s stock after selling 494,986 shares during the period. Ameriprise Financial Inc.’s holdings in Iovance Biotherapeutics […] - 2025-06-05 04:22:52
Captrust Financial Advisors Cuts Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA): Captrust Financial Advisors lowered its position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 42.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 28,738 shares of the biotechnology company’s stock after selling 20,868 shares during the period. Captrust Financial Advisors’ […] - 2025-05-23 04:47:02
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030: Resilient and growing. Those two descriptions definitely apply to the healthcare sector. People need healthcare products and services regardless of what's happening with the economy. And with elderly populations increasing in many countries (including the U.S.), the demand for he - 2025-05-21 05:48:00
Iovance Biotherapeutics (NASDAQ:IOVA) Rating Lowered to “Neutral” at UBS Group: UBS Group lowered shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) from a buy rating to a neutral rating in a report issued on Friday morning, Marketbeat.com reports. UBS Group currently has $2.00 price target on the biotechnology company’s stock, down from their prior price target of $17.00. Other equities research analysts also recently issued […] - 2025-05-19 02:46:52
Is This Beaten-Down Stock a Buy Near Its 52-Week Low?: Penny stocks -- companies with shares trading at around $5 or even less apiece -- usually carry above-average risk. However, there may be hidden gems among them: companies with attractive prospects that continue to be ignored by most investors. Identifying those penny stocks with - 2025-05-15 06:14:00
Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 5.4% Following Analyst Downgrade: Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report)’s share price fell 5.4% during mid-day trading on Tuesday after The Goldman Sachs Group lowered their price target on the stock from $16.00 to $8.00. The Goldman Sachs Group currently has a buy rating on the stock. Iovance Biotherapeutics traded as low as $1.85 and last traded […] - 2025-05-15 02:39:11
Iovance Biotherapeutics (NASDAQ:IOVA) Downgraded by Truist Financial to Hold: Truist Financial cut shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) from a buy rating to a hold rating in a research report sent to investors on Monday morning, MarketBeat.com reports. A number of other equities research analysts also recently weighed in on the company. Chardan Capital lowered their price target on Iovance Biotherapeutics from […] - 2025-05-13 02:56:46
Pre-Market Most Active for May 9, 2025 : TSLL, SQQQ, TQQQ, QBTS, IOVA, WOLF, NVDA, IBIT, DNB, UMC, HIMS, AEG: The NASDAQ 100 Pre-Market Indicator is up 91.45 to 20,155.02. The total Pre-Market volume is currently 99,990,466 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is +0.2 at $10.57, with 10,864,676 share - 2025-05-09 09:28:55
My 3 Favorite Stocks to Buy Right Now: Veteran investors know that the market's recent weakness is more of an opportunity than an omen. Sure, stocks may not have hit their ultimate bottom just yet. They're arguably closer to it than not, though. And five years from now, you won't care if you stepped in at the exact lo - 2025-05-06 04:15:00
First Trust Advisors LP Invests $2.40 Million in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA): First Trust Advisors LP acquired a new position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 324,246 shares of the biotechnology company’s stock, valued at approximately $2,399,000. A number of other institutional investors also […] - 2025-05-05 05:10:51
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Stock Holdings Lessened by CANADA LIFE ASSURANCE Co: CANADA LIFE ASSURANCE Co cut its stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 5.7% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 57,265 shares of the biotechnology company’s stock after selling 3,484 shares during the period. CANADA LIFE ASSURANCE Co’s holdings […] - 2025-05-01 05:38:58
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Stake Raised by Invesco Ltd.: Invesco Ltd. lifted its holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 2.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 221,928 shares of the biotechnology company’s stock after acquiring an additional 4,967 shares during the quarter. Invesco Ltd.’s holdings in Iovance Biotherapeutics were worth $1,642,000 at the end of the most […] - 2025-04-30 04:46:52

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) IOVA holdings

Date	Number of IOVA Shares Held	Base Market Value of IOVA Shares	Local Market Value of IOVA Shares	Change in IOVA Shares Held	Change in IOVA Base Value	Current Price per IOVA Share Held	Previous Price per IOVA Share Held
2025-12-03 (Wednesday)	246,901	USD 545,651	USD 545,651	0	USD 18,517	USD 2.21	USD 2.135
2025-12-02 (Tuesday)	246,901	USD 527,134	USD 527,134	8,955	USD -3,486	USD 2.135	USD 2.23
2025-12-01 (Monday)	237,946	USD 530,620	USD 530,620	0	USD -57,107	USD 2.23	USD 2.47
2025-11-28 (Friday)	237,946	USD 587,727	USD 587,727	596	USD 8,593	USD 2.47	USD 2.44
2025-11-27 (Thursday)	237,350	USD 579,134	USD 579,134	0	USD 0	USD 2.44	USD 2.44
2025-11-26 (Wednesday)	237,350	USD 579,134	USD 579,134	1,785	USD -5,067	USD 2.44	USD 2.48
2025-11-25 (Tuesday)	235,565	USD 584,201	USD 584,201	2,975	USD 2,726	USD 2.48	USD 2.5
2025-11-24 (Monday)	232,590	USD 581,475	USD 581,475	597	USD 61,811	USD 2.5	USD 2.24
2025-11-21 (Friday)	231,993	USD 519,664	USD 519,664	0	USD 13,919	USD 2.24	USD 2.18
2025-11-20 (Thursday)	231,993	USD 505,745	USD 505,745	-2,372	USD -23,920	USD 2.18	USD 2.26
2025-11-19 (Wednesday)	234,365	USD 529,665	USD 529,665	592	USD -40,741	USD 2.26	USD 2.44
2025-11-18 (Tuesday)	233,773	USD 570,406	USD 570,406	3,552	USD 13,271	USD 2.44	USD 2.42
2025-11-17 (Monday)	230,221	USD 557,135	USD 557,135	1,184	USD -8,586	USD 2.42	USD 2.47

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IOVA by Blackrock for IE00BDZVHG35

Show aggregate share trades of IOVA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 8,955 2.269 2.130 2.144 USD 19,199 4.17
2025-11-28 BUY 596 2.480 2.400 2.408 USD 1,435 4.19
2025-11-26 BUY 1,785 2.500 2.410 2.419 USD 4,318 4.20
2025-11-26 BUY 1,785 2.500 2.410 2.419 USD 4,318 4.20
2025-11-25 BUY 2,975 2.540 2.410 2.423 USD 7,208 4.21
2025-11-24 BUY 597 2.545 2.250 2.280 USD 1,361 4.22
2025-11-20 SELL -2,372 2.360 2.160 2.180 USD -5,171 4.24 Profit of 4,887 on sale
2025-11-19 BUY 592 2.440 2.220 2.242 USD 1,327 4.25
2025-11-18 BUY 3,552 2.620 2.360 2.386 USD 8,475 4.26
2025-11-17 BUY 1,184 2.540 2.360 2.378 USD 2,816 4.27
2025-11-14 BUY 592 2.520 2.340 2.358 USD 1,396 4.28
2025-11-12 BUY 591 2.720 2.470 2.495 USD 1,475 4.30
2025-11-10 BUY 589 2.600 2.350 2.375 USD 1,399 4.32
2025-11-07 BUY 592 2.300* 4.33
2025-11-04 BUY 594 1.930 1.805 1.817 USD 1,080 4.37
2025-10-30 BUY 2,970 2.070 1.935 1.948 USD 5,787 4.40
2025-10-29 BUY 1,188 2.000 2.170 2.153 USD 2,558 4.42
2025-10-22 SELL -2,360 2.150 2.250 2.240 USD -5,286 4.48 Profit of 5,288 on sale
2025-10-20 BUY 1,180 2.320 2.410 2.401 USD 2,833 4.51
2025-10-17 BUY 2,945 2.180 2.240 2.234 USD 6,579 4.52
2025-10-15 BUY 4,680 2.240 2.270 2.267 USD 10,610 4.53
2025-10-03 BUY 4,158 2.340 2.350 2.349 USD 9,767 4.56
2025-10-02 BUY 594 2.250 2.280 2.277 USD 1,353 4.57
2025-09-30 BUY 1,186 2.170 2.250 2.242 USD 2,659 4.60
2025-09-26 BUY 1,188 2.110 2.110 2.110 USD 2,507 4.63
2025-09-25 BUY 1,188 2.020 2.090 2.083 USD 2,475 4.65
2025-09-18 BUY 598 2.200 2.340 2.326 USD 1,391 4.66
2025-09-17 BUY 1,797 2.220 2.350 2.337 USD 4,200 4.68
2025-09-11 SELL -594 2.420 2.460 2.456 USD -1,459 4.71 Profit of 1,337 on sale
2025-09-10 BUY 1,190 2.380 2.380 2.380 USD 2,832 4.72
2025-07-17 SELL -1,176 2.340 2.500 2.484 USD -2,921 4.78 Profit of 2,702 on sale
2025-07-11 SELL -4,744 1.870 1.930 1.924 USD -9,127 4.86 Profit of 13,905 on sale
2025-07-02 BUY 32,670 1.750 1.800 1.795 USD 58,643 4.94
2025-06-25 BUY 1,182 1.780 1.890 1.879 USD 2,221 5.03
2025-06-20 BUY 13,101 1.980 2.090 2.079 USD 27,237 5.09
2025-06-11 BUY 1,098 2.240 2.430 2.411 USD 2,647 5.25
2025-06-10 BUY 1,100 2.380 2.470 2.461 USD 2,707 5.27
2025-06-04 SELL -554 1.830 1.870 1.866 USD -1,034 5.37 Profit of 1,943 on sale
2025-04-23 BUY 543 3.190 3.430 3.406 USD 1,849 6.28
2025-04-10 SELL -4,336 3.060 3.160 3.150 USD -13,658 6.59 Profit of 14,927 on sale
2025-04-08 SELL -542 2.850 3.200 3.165 USD -1,715 6.67 Profit of 1,902 on sale
2025-04-07 SELL -542 3.030 3.190 3.174 USD -1,720 6.72 Profit of 1,920 on sale
2025-04-04 SELL -2,720 3.000 3.200 3.180 USD -8,650 6.76 Profit of 9,737 on sale
2025-04-01 BUY 2,244 3.250 3.350 3.340 USD 7,495 6.84
2025-03-31 SELL -1,635 3.330 3.420 3.411 USD -5,577 6.88 Profit of 5,678 on sale
2025-03-21 BUY 17,989 3.540 3.580 3.576 USD 64,329 7.15
2025-03-14 SELL -7,824 3.590 3.620 3.617 USD -28,299 7.40 Profit of 29,575 on sale
2025-03-07 SELL -972 3.750 3.800 3.795 USD -3,689 7.67 Profit of 3,770 on sale
2025-03-04 SELL -486 3.920 3.960 3.956 USD -1,923 7.85 Profit of 1,894 on sale
2025-02-25 BUY 968 5.340 5.590 5.565 USD 5,387 8.11
2025-02-19 SELL -482 5.650 5.730 5.722 USD -2,758 8.30 Profit of 1,240 on sale
2025-02-13 BUY 1,443 5.340 5.420 5.412 USD 7,810 8.52
2025-02-12 BUY 482 5.340 5.430 5.421 USD 2,613 8.58
2025-02-11 BUY 1,924 5.290 5.340 5.335 USD 10,265 8.65
2024-12-30 SELL -16,199 7.170 7.340 7.323 USD -118,625 9.78 Profit of 39,857 on sale
2024-11-18 SELL -7,833 8.430 8.650 8.628 USD -67,583 10.83 Profit of 17,226 on sale
2024-11-08 SELL -522 10.590 10.800 10.779 USD -5,627 10.93 Profit of 77 on sale
2024-10-21 SELL -523 9.920 10.180 10.154 USD -5,311 0.00 Loss of -5,311 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	8,955	2.269	2.130	2.144	USD 19,199	4.17
2025-11-28	BUY	596	2.480	2.400	2.408	USD 1,435	4.19
2025-11-26	BUY	1,785	2.500	2.410	2.419	USD 4,318	4.20
2025-11-26	BUY	1,785	2.500	2.410	2.419	USD 4,318	4.20
2025-11-25	BUY	2,975	2.540	2.410	2.423	USD 7,208	4.21
2025-11-24	BUY	597	2.545	2.250	2.280	USD 1,361	4.22
2025-11-20	SELL	-2,372	2.360	2.160	2.180	USD -5,171	4.24 Profit of 4,887 on sale
2025-11-19	BUY	592	2.440	2.220	2.242	USD 1,327	4.25
2025-11-18	BUY	3,552	2.620	2.360	2.386	USD 8,475	4.26
2025-11-17	BUY	1,184	2.540	2.360	2.378	USD 2,816	4.27
2025-11-14	BUY	592	2.520	2.340	2.358	USD 1,396	4.28
2025-11-12	BUY	591	2.720	2.470	2.495	USD 1,475	4.30
2025-11-10	BUY	589	2.600	2.350	2.375	USD 1,399	4.32
2025-11-07	BUY	592			2.300*		4.33
2025-11-04	BUY	594	1.930	1.805	1.817	USD 1,080	4.37
2025-10-30	BUY	2,970	2.070	1.935	1.948	USD 5,787	4.40
2025-10-29	BUY	1,188	2.000	2.170	2.153	USD 2,558	4.42
2025-10-22	SELL	-2,360	2.150	2.250	2.240	USD -5,286	4.48 Profit of 5,288 on sale
2025-10-20	BUY	1,180	2.320	2.410	2.401	USD 2,833	4.51
2025-10-17	BUY	2,945	2.180	2.240	2.234	USD 6,579	4.52
2025-10-15	BUY	4,680	2.240	2.270	2.267	USD 10,610	4.53
2025-10-03	BUY	4,158	2.340	2.350	2.349	USD 9,767	4.56
2025-10-02	BUY	594	2.250	2.280	2.277	USD 1,353	4.57
2025-09-30	BUY	1,186	2.170	2.250	2.242	USD 2,659	4.60
2025-09-26	BUY	1,188	2.110	2.110	2.110	USD 2,507	4.63
2025-09-25	BUY	1,188	2.020	2.090	2.083	USD 2,475	4.65
2025-09-18	BUY	598	2.200	2.340	2.326	USD 1,391	4.66
2025-09-17	BUY	1,797	2.220	2.350	2.337	USD 4,200	4.68
2025-09-11	SELL	-594	2.420	2.460	2.456	USD -1,459	4.71 Profit of 1,337 on sale
2025-09-10	BUY	1,190	2.380	2.380	2.380	USD 2,832	4.72
2025-07-17	SELL	-1,176	2.340	2.500	2.484	USD -2,921	4.78 Profit of 2,702 on sale
2025-07-11	SELL	-4,744	1.870	1.930	1.924	USD -9,127	4.86 Profit of 13,905 on sale
2025-07-02	BUY	32,670	1.750	1.800	1.795	USD 58,643	4.94
2025-06-25	BUY	1,182	1.780	1.890	1.879	USD 2,221	5.03
2025-06-20	BUY	13,101	1.980	2.090	2.079	USD 27,237	5.09
2025-06-11	BUY	1,098	2.240	2.430	2.411	USD 2,647	5.25
2025-06-10	BUY	1,100	2.380	2.470	2.461	USD 2,707	5.27
2025-06-04	SELL	-554	1.830	1.870	1.866	USD -1,034	5.37 Profit of 1,943 on sale
2025-04-23	BUY	543	3.190	3.430	3.406	USD 1,849	6.28
2025-04-10	SELL	-4,336	3.060	3.160	3.150	USD -13,658	6.59 Profit of 14,927 on sale
2025-04-08	SELL	-542	2.850	3.200	3.165	USD -1,715	6.67 Profit of 1,902 on sale
2025-04-07	SELL	-542	3.030	3.190	3.174	USD -1,720	6.72 Profit of 1,920 on sale
2025-04-04	SELL	-2,720	3.000	3.200	3.180	USD -8,650	6.76 Profit of 9,737 on sale
2025-04-01	BUY	2,244	3.250	3.350	3.340	USD 7,495	6.84
2025-03-31	SELL	-1,635	3.330	3.420	3.411	USD -5,577	6.88 Profit of 5,678 on sale
2025-03-21	BUY	17,989	3.540	3.580	3.576	USD 64,329	7.15
2025-03-14	SELL	-7,824	3.590	3.620	3.617	USD -28,299	7.40 Profit of 29,575 on sale
2025-03-07	SELL	-972	3.750	3.800	3.795	USD -3,689	7.67 Profit of 3,770 on sale
2025-03-04	SELL	-486	3.920	3.960	3.956	USD -1,923	7.85 Profit of 1,894 on sale
2025-02-25	BUY	968	5.340	5.590	5.565	USD 5,387	8.11
2025-02-19	SELL	-482	5.650	5.730	5.722	USD -2,758	8.30 Profit of 1,240 on sale
2025-02-13	BUY	1,443	5.340	5.420	5.412	USD 7,810	8.52
2025-02-12	BUY	482	5.340	5.430	5.421	USD 2,613	8.58
2025-02-11	BUY	1,924	5.290	5.340	5.335	USD 10,265	8.65
2024-12-30	SELL	-16,199	7.170	7.340	7.323	USD -118,625	9.78 Profit of 39,857 on sale
2024-11-18	SELL	-7,833	8.430	8.650	8.628	USD -67,583	10.83 Profit of 17,226 on sale
2024-11-08	SELL	-522	10.590	10.800	10.779	USD -5,627	10.93 Profit of 77 on sale
2024-10-21	SELL	-523	9.920	10.180	10.154	USD -5,311	0.00 Loss of -5,311 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IOVA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	3,532,234	6,486	7,668,983	46.1%
2025-09-18	2,284,753	4,816	5,499,983	41.5%
2025-09-17	1,925,501	858	4,834,766	39.8%
2025-09-16	1,602,514	3,001	5,745,094	27.9%
2025-09-15	1,315,142	0	3,744,728	35.1%
2025-09-12	1,553,885	0	5,376,818	28.9%
2025-09-11	1,444,534	29,200	5,013,701	28.8%
2025-09-10	2,044,828	0	6,227,128	32.8%
2025-09-09	2,298,797	2,662	6,167,909	37.3%
2025-09-08	1,918,024	1	5,763,198	33.3%
2025-09-05	2,591,012	9,173	9,480,157	27.3%
2025-09-04	1,500,394	13,810	4,107,381	36.5%
2025-09-03	1,378,128	0	4,349,267	31.7%
2025-09-02	1,666,705	2,167	5,347,659	31.2%
2025-08-29	1,159,171	5,713	3,980,994	29.1%
2025-08-28	2,392,970	2,594	7,349,544	32.6%
2025-08-27	1,280,659	236	5,717,986	22.4%
2025-08-26	1,640,488	1,373	5,239,061	31.3%
2025-08-25	1,887,897	5,024	7,003,257	27.0%
2025-08-22	1,881,123	2,035	6,305,068	29.8%
2025-08-21	2,014,406	12,600	6,384,638	31.6%
2025-08-20	1,275,755	1,780	5,830,138	21.9%
2025-08-19	7,448,382	15,060	14,553,520	51.2%
2025-08-18	1,267,213	3,666	4,514,177	28.1%
2025-08-15	1,712,990	27,785	4,919,188	34.8%
2025-08-14	2,320,736	25,101	6,194,763	37.5%
2025-08-13	3,315,382	2,645	8,468,000	39.2%
2025-08-12	3,404,863	0	8,950,841	38.0%
2025-08-11	3,292,404	466,161	8,339,261	39.5%
2025-08-08	11,368,387	839,077	22,629,740	50.2%
2025-08-07	3,657,125	622	9,790,535	37.4%
2025-08-06	2,230,646	0	6,811,619	32.7%
2025-08-05	1,376,618	1,540	4,840,458	28.4%
2025-08-04	2,606,740	6,724	6,273,534	41.6%
2025-08-01	3,458,013	384	8,472,964	40.8%
2025-07-31	2,782,193	188,883	7,020,877	39.6%
2025-07-30	4,313,143	99,900	10,922,395	39.5%
2025-07-29	2,439,068	2,400	8,572,481	28.5%
2025-07-28	5,144,287	20,693	11,611,935	44.3%
2025-07-25	4,787,166	587,768	13,516,495	35.4%
2025-07-24	10,773,627	688,612	22,380,070	48.1%
2025-07-23	33,356,596	146,107	54,914,895	60.7%
2025-07-22	12,195,989	30,402	24,964,953	48.9%
2025-07-21	3,771,670	34,435	11,100,076	34.0%
2025-07-18	3,360,316	14,176	8,564,863	39.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE